Metformin Hydrochloride Amarox

Metformin Hydrochloride, the active ingredient in Metformin Hydrochloride Amarox, is a biguanide presented as an oral tablet for oral use. It treats type 2 diabetes mellitus in adult patients. GNH USA supplies Metformin Hydrochloride Amarox as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformin Hydrochloride is an oral antidiabetic that lowers blood glucose in the type 2 diabetes pathway. - Type 2 diabetes mellitus: improves glycaemic control when combined with diet and exercise. - Adjunct therapy in combination with other antidiabetic agents: enhances overall glucose‑lowering effect. - Monotherapy when lifestyle measures alone are insufficient: provides first‑line glucose reduction.

Metformin Hydrochloride may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhoea: frequent loose stools, often transient. - Metallic taste: transient alteration of taste perception. - Abdominal discomfort: cramping or bloating. - Weight loss: modest reduction in body weight.

Serious or Rare Side Effects: - Lactic acidosis: rare but potentially fatal metabolic acidosis. - Severe skin reactions: such as Stevens‑Johnson syndrome. - Hepatic dysfunction: elevated liver enzymes or hepatitis. - Pancreatitis: inflammation of the pancreas. - Hypoglycaemia (when combined with insulin or sulfonylureas): low blood sugar episodes.

Metformin Hydrochloride requires careful patient assessment before and during therapy. - Renal function assessment: evaluate eGFR prior to initiation and periodically thereafter. - Lactic acidosis risk: avoid in patients with severe renal or hepatic impairment. - Alcohol consumption: limit intake to reduce acidosis risk. - Pregnancy and lactation: discuss potential benefits and risks with a healthcare professional. - Drug interactions: review concomitant medications for possible interactions. - Store at ambient temperature: keep in the original container, protect from moisture and heat.

Metformin Hydrochloride can interact with several medicines, requiring vigilance.

Major Interactions (Avoid): - Iodinated contrast media: may precipitate acute renal failure and increase lactic acidosis risk. - Cimetidine: can raise metformin plasma concentrations. - Nitrates: combined use may enhance the risk of lactic acidosis.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask symptoms of hypoglycaemia. - Thiazide diuretics: can attenuate glucose‑lowering effect. - ACE inhibitors or ARBs: monitor renal function and potassium levels.